Carlos López-Larrea Selected Research

MICB antigen

4/2008

Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos López-Larrea Research Topics

Disease

10	Ankylosing Spondylitis 01/2016 - 08/2002
8	Neoplasms (Cancer) 01/2021 - 10/2006
6	Infections 10/2021 - 03/2004
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014 - 03/2003
4	COVID-19 10/2021 - 12/2020
4	Psoriatic Arthritis 01/2014 - 05/2002
3	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 11/2018
3	Autoimmune Diseases (Autoimmune Disease) 02/2014 - 04/2008
3	Arthritis (Polyarthritis) 11/2013 - 03/2003
3	Spondylarthropathies 01/2009 - 08/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 03/2004
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
2	Hypertension (High Blood Pressure) 06/2018 - 07/2010
2	Type 2 Diabetes Mellitus (MODY) 06/2018 - 05/2011
2	Chronic Hepatitis C 01/2017 - 06/2012
2	Persistent Infection 09/2015 - 10/2011
2	Celiac Disease (Celiac Sprue) 02/2014 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 07/2005 - 03/2004
2	Crohn Disease (Crohn's Disease) 05/2003 - 09/2002
1	Inflammation (Inflammations) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2015
1	Chronic Renal Insufficiency 03/2015
1	Heart Failure 07/2014
1	Proteinuria 01/2014
1	Virus Diseases (Viral Diseases) 08/2011
1	Atherosclerosis 01/2011
1	Myocardial Infarction 01/2011
1	Teratocarcinoma 04/2010
1	HIV Infections (HIV Infection) 08/2009
1	Spondylarthritis (Spinal Arthritis) 01/2009
1	Reactive Arthritis (Reiter Disease) 11/2008
1	Relapsing-Remitting Multiple Sclerosis 04/2008
1	Multiple Sclerosis 04/2008
1	End Stage Liver Disease 03/2004
1	Disease Susceptibility (Diathesis) 03/2003
1	Fistula 09/2002
1	Fibrosis (Cirrhosis) 04/2002
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 04/2002

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2021 - 10/2006
7	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2011 - 08/2002
6	AntigensIBA 01/2019 - 08/2009
6	HLA-B Antigens (HLA-B)IBA 01/2016 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2002
4	micaIBA 02/2014 - 05/2002
4	HLA-C Antigens (HLA-C)IBA 01/2014 - 11/2005
4	HLA Antigens (Human Leukocyte Antigens)IBA 06/2013 - 03/2003
3	CytokinesIBA 10/2021 - 09/2002
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 11/2018
3	Peptides (Polypeptides)IBA 01/2019 - 02/2014
3	KIR ReceptorsIBA 01/2014 - 07/2005
2	Genetic Markers (Genetic Marker)IBA 09/2021 - 01/2017
2	InterferonsIBA 01/2021 - 01/2017
2	ProteomeIBA 01/2019 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 03/2004
2	Interleukin-6 (Interleukin 6)IBA 07/2014 - 09/2002
2	HLA-DPA1 antigen (HLA DPA1)IBA 06/2013 - 11/2011
2	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2013 - 10/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 03/2004 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2003 - 09/2002
1	MicroRNAs (MicroRNA)IBA 01/2022
1	VaccinesIBA 10/2021
1	Chemokine ReceptorsIBA 09/2021
1	Natural Cytotoxicity Triggering Receptor 3IBA 01/2021
1	AngiotensinsIBA 12/2020
1	EnzymesIBA 12/2020
1	AminopeptidasesIBA 01/2020
1	NF-kappa B (NF-kB)IBA 06/2018
1	CholesterolIBA 06/2018
1	AutoantibodiesIBA 02/2014
1	Glutens (Glutelin)IBA 02/2014
1	AntibodiesIBA 02/2014
1	CreatinineIBA 01/2014
1	AutoantigensIBA 01/2013
1	HLA-DPB1 antigen (HLA DPB1)IBA 11/2011
1	KCNQ1 Potassium ChannelIBA 05/2011
1	Mitochondrial DNA (mtDNA)IBA 01/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	NucleotidesIBA 07/2010
1	Cytochrome P-450 CYP3AIBA 07/2010
1	SodiumIBA 07/2010
1	Histocompatibility Antigens Class IIIBA 04/2010
1	MICB antigenIBA 04/2008
1	EpitopesIBA 07/2005
1	KIR3DS1 ReceptorsIBA 07/2005
1	TransglutaminasesIBA 06/2005
1	Alanine Transaminase (SGPT)IBA 03/2004
1	HLA-DQB1 antigen (HLA DQB1)IBA 03/2004
1	HLA-DR11 antigenIBA 03/2004
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2002
1	Infliximab (Remicade)FDA Link 09/2002
1	Monoclonal AntibodiesIBA 09/2002
1	Transferrin (beta 2 Transferrin)IBA 04/2002
1	IronIBA 04/2002

Therapy/Procedure

2	Immunotherapy 01/2019 - 11/2018
2	Therapeutics 01/2019 - 06/2012
2	Transplantation 01/2014 - 08/2011
1	Gluten-Free Diet 02/2014